GSK pulling casopitant applications

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) is withdrawing all regulatory applications for casopitant to treat chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV),...